Cherington Charles's Form 4 filing
Comera Life Sciences Holdings, Inc. (CMRA) · filed Oct 18, 2022
- Accession no.
- 0001062993-22-020905
- Filed
- Oct 18, 2022
- Trade date
- Oct 14-17, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $32.1K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Cherington CharlesCIK 0001448698 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 14, 2022 | Common Stock | PPurchaseAcquired | +4,253 | $1.60 | +$6,804.8 | 619,664 | Direct | |
| Oct 17, 2022 | Common Stock | PPurchaseAcquired | +15,266 | $1.66 | +$25,341.56 | 634,930 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.